As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
Articles
-
-
Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel
-
Neurocognitive impairment and evidence-based treatment options in Bipolar disorder
-
A cross-sectional study on metabolic similarities and differences between inpatients with schizophrenia and those with mood disorders
-
Untreated depressive symptoms significantly worsen quality of life in old age and may lead to the misdiagnosis of dementia: a cross-sectional study
-
A cross-sectional analysis of video games and attention deficit hyperactivity disorder symptoms in adolescents
-
Depression and Obstructive Sleep Apnea (OSA)
-
Hospital Anxiety and Depression Scale (HADS): validation in a Greek general hospital sample
-
Guidelines for rating Global Assessment of Functioning (GAF)
-
No aggression in a 4-year-old boy with an androgen-producing tumour: Case Report
Aims and scope
Annals of General Psychiatry considers manuscripts on all aspects of psychiatry, including neuroscience and psychological medicine. Both basic and clinical neuroscience contributions are encouraged.
Annals of General Psychiatry emphasizes a biopsychosocial approach to illness and health and strongly supports and follows the principles of evidence-based medicine. As an open access journal, Annals of General Psychiatry facilitates the worldwide distribution of high quality psychiatry and mental health research. The journal considers submissions on a wide range of topics including, but not limited to, psychopharmacology, forensic psychiatry, psychotic disorders, psychiatric genetics, and mood and anxiety disorders.
Featured article: Dietary total antioxidant capacity is inversely associated with depression, anxiety and some oxidative stress biomarkers in postmenopausal women
"Postmenopausal women are at higher risk of mental disorders. Oxidative stress has implication in the development of these disorders... An inverse relationship was found between dietary total antioxidant capacity (DTAC) with depression, anxiety scores and some oxidative stress biomarkers in postmenopausal women. These findings indicate DTAC may be used for developing effective dietary measures for reducing depression and anxiety in these women."
Affiliated with
-
Official publication of the International Society of Neurobiology and Psychopharmacology.
Annual Journal Metrics
-
Speed
123 days to first decision for reviewed manuscripts only
85 days to first decision for all manuscripts
238 days from submission to acceptance
12 days from acceptance to publicationCitation Impact
2.157 - 2-year Impact Factor
2.222 - 5-year Impact Factor
0.964 - Source Normalized Impact per Paper (SNIP)
0.813 - SCImago Journal Rank (SJR)Usage
457,834 Downloads
115 Altmetric mentions
